Roche bags CE Mark for automated mass spectrometry antibiotics monitoring
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Enabling a new era in minimally invasive obesity treatment across Europe
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks
This predictive technology empowers people with diabetes to take preventive action before complications arise
The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Revolutionary ovarian cancer rapid test available Q4 2022
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods
Subscribe To Our Newsletter & Stay Updated